Certara Q2 revenue rises 1% to $93.3 million; net loss $6.1 million
Certara reported second-quarter 2026 revenue of $93.3 million, up 1% from a year earlier, but swung to a continuing-operations net loss of $6.1 million from a $1.5 million profit. Total net loss attributable to common stockholders was $55.3 million, including a $49.2 million loss from discontinued operations tied to the divested Regulatory and Medical Writing business. The company reaffirmed its 2026 revenue growth guidance of 0% to 4%, while shareholders also received updated adjusted EBITDA margin and adjusted EPS guidance.
Key points
- Software revenue rose 4% to $48.8 million, while services revenue fell 3% to $44.5 million.
- Adjusted EBITDA was $26.2 million, down from $27.0 million; diluted loss per share from continuing operations was $(0.04) versus $0.01 a year earlier.
- The company completed a $100 million share repurchase program and the board approved an additional $50 million.
- Julien Perrier was appointed Chief Commercial Officer effective August 1, 2026.
The filing
Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.